Saltar al contenido
Merck
Todas las fotos(1)

Key Documents

Otros documentos

E4550

Sigma-Aldrich

Diethylene glycol monoethyl ether

≥99%

Sinónimos:

2-(2-Ethoxyethoxy)ethanol, CARBITOL™, Diethylene glycol ethyl ether, Ethyldiglycol

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula lineal:
C2H5OCH2CH2OCH2CH2OH
Número de CAS:
111-90-0
Peso molecular:
134.17
Beilstein/REAXYS Number:
1736441
EC Number:
203-919-7
MDL number:
MFCD00002872
UNSPSC Code:
12352112
PubChem Substance ID:
329799059
NACRES:
NA.21

vapor density

4.63 (vs air)

Quality Level

200

vapor pressure

0.12 mmHg ( 20 °C)

assay

≥99%

form

liquid

expl. lim.

1.2 %, 135 °F
23.5 %, 182 °F

technique(s)

gas chromatography (GC): suitable

refractive index

n20/D 1.427 (lit.)

bp

202 °C (lit.)

mp

-80 °C (lit.)

density

0.999 g/mL at 25 °C (lit.)

SMILES string

CCOCCOCCO

InChI

1S/C6H14O3/c1-2-8-5-6-9-4-3-7/h7H,2-6H2,1H3

InChI key

XXJWXESWEXIICW-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Legal Information

CARBITOL is a trademark of The Dow Chemical Company or an affiliated company of Dow

Storage Class

10 - Combustible liquids

wgk_germany

WGK 1

flash_point_f

204.8 °F - closed cup

flash_point_c

96 °C - closed cup

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Yousef Javadzadeh et al.
Colloids and surfaces. B, Biointerfaces, 82(2), 422-426 (2010-10-19)
Regarding the potential severe toxicity associated with systemic administration of methotrexate (MTX), a topical formulation might be of greater utility for the treatment of psoriasis and other hyperproliferative skin disorders. One of the presumed reasons for the lack of clinical
Liandong Hu et al.
International journal of pharmaceutics, 420(2), 251-255 (2011-09-13)
The objective of the present study was to formulate a microemulsion system for oral administration to improve the solubility and bioavailability of fenofibrate. Various formulations were prepared using different ratios of oils, surfactants and co-surfactants (S&CoS). Pseudo-ternary phase diagrams were
Dong Hoon Oh et al.
International journal of pharmaceutics, 420(2), 412-418 (2011-09-29)
In order to compare the effects of hydrophilic and hydrophobic solid carrier on the formation of solid self-microemulsifying drug delivery system (SMEDDS), two solid SMEDDS formulations were prepared by spray-drying the solutions containing liquid SMEDDS and solid carriers. Colloidal silica
Hyun-Jong Cho et al.
International journal of pharmaceutics, 423(2), 153-160 (2012-01-03)
To achieve rapid onset of action and improved bioavailability of udenafil, a microemulsion system was developed for its intranasal delivery. Phase behavior, particle size, transmission electron microscope (TEM) images, and the drug solubilization capacity of the microemulsion were investigated. A
Roberta Censi et al.
Drug development and industrial pharmacy, 38(9), 1128-1133 (2011-12-23)
A microemulsion for the cutaneous release of quercetin was prepared. An aqueous phase, containing 40% Transcutol® P as solubilizing agent and permeation enhancer, was emulsified with Labrafil® as oil phase and Labrasol®/Capryol™ 90 as Solvent/Co-solvent. Quercetin was dissolved in the
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico